Medicament classification turns on common parlance and Ayurvedic text evidence for excise tariff treatment

Classification of Vicks VapoRub and Vicks Inhaler under the Central Excise Tariff turned on common parlance understanding and whether the ingredients were shown in authoritative Ayurvedic texts. Section 3(a) of the Drugs and Cosmetics Act, 1940 was treated as not determinative for excise classification. For Vicks VapoRub, the material was considered relevant evidence of Ayurvedic character, and the assessee was entitled to de novo consideration under Tariff Heading 3003.30 if all ingredients were shown in authoritative Ayurvedic books. For Vicks Inhaler, the Tribunal found insufficient material for final classification and required fresh determination on the same factual tests, leaving tariff treatment open.

---

---

Issues: (i) whether Vicks VapoRub is classifiable as a medicament falling under Tariff Heading 3003.30 of the Central Excise Tariff Act, 1985 or as a patent or proprietary medicament under Tariff Heading 3003.19; (ii) whether Vicks Inhaler is classifiable under Tariff Heading 3003.30 or under Tariff Heading 3003.19.

Issue (i): whether Vicks VapoRub is classifiable as a medicament falling under Tariff Heading 3003.30 of the Central Excise Tariff Act, 1985 or as a patent or proprietary medicament under Tariff Heading 3003.19.

Analysis: The classification turned on the common parlance understanding of the product and on whether its ingredients were shown to be recognised in authoritative Ayurvedic texts. The definition in Section 3(a) of the Drugs and Cosmetics Act, 1940 was treated as not determinative for central excise classification. The product was found to answer the common parlance test as an Ayurvedic medicine, and the certificates and other material relied upon by the assessee were regarded as having evidentiary value, though not conclusive by themselves.

Conclusion: The product was not finally classified by the Tribunal, but the assessee was held entitled to de-novo consideration for classification under Tariff Heading 3003.30 if all ingredients are shown to be mentioned in authoritative Ayurvedic books.

Issue (ii): whether Vicks Inhaler is classifiable under Tariff Heading 3003.30 or under Tariff Heading 3003.19.

Analysis: The Tribunal found insufficient material on common parlance treatment of the product as an Ayurvedic medicine, but noted references showing nasal administration in Ayurvedic texts and treated the product as having medicament character. The issue was therefore required to be examined afresh on two factual questions: whether the product is known in common parlance as Ayurvedic medicine and whether all its ingredients are mentioned in authoritative Ayurvedic books. Section 3(a) of the Drugs and Cosmetics Act, 1940 was again held not to govern the excise classification directly.

Conclusion: The product was not finally classified by the Tribunal, and the matter was remanded for de-novo determination on the relevant factual tests.

Final Conclusion: The impugned order was set aside and the entire matter was remanded for fresh examination on the limited classification questions, leaving the final tariff treatment open to be decided by the Assistant Collector.

Ratio Decidendi: Where a statute governing excise classification does not define a term, classification of medicinal products is determined by the relevant excise tariff framework and the common parlance understanding of the goods, with Ayurvedic ingredient references in authoritative texts serving as a material but not exclusive consideration.

---